These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Lau SK, Prakash S, Geller SA, Alsabeh R. Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785 [Abstract] [Full Text] [Related]
4. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL. Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137 [Abstract] [Full Text] [Related]
6. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma. Röcken C, Licht J, Roessner A, Carl-McGrath S. J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153 [Abstract] [Full Text] [Related]
8. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19. Tsuji M, Kashihara T, Terada N, Mori H. Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850 [Abstract] [Full Text] [Related]
9. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P. Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [Abstract] [Full Text] [Related]
11. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material. Al-Muhannadi N, Ansari N, Brahmi U, Satir AA. Ann Hepatol; 2011 Dec; 10(4):508-15. PubMed ID: 21911893 [Abstract] [Full Text] [Related]
12. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Chu PG, Ishizawa S, Wu E, Weiss LM. Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084 [Abstract] [Full Text] [Related]
16. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma. Lagana SM, Salomao M, Remotti HE, Knisely AS, Moreira RK. Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077 [Abstract] [Full Text] [Related]
17. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. Lin F, Abdallah H, Meschter S. Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758 [Abstract] [Full Text] [Related]
19. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma. Jin GZ, Yu WL, Dong H, Zhou WP, Gu YJ, Yu H, Yu H, Lu XY, Xian ZH, Liu YK, Cong WM, Wu MC. J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285 [Abstract] [Full Text] [Related]
20. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology. Chikhale M, Toi PC, Siddaraju N, Ananthakrishnan R. Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782 [Abstract] [Full Text] [Related] Page: [Next] [New Search]